NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 3 filers reported holding NEOGENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,936 | -23.5% | 320 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $5,142 | +85600.0% | 320 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $6 | +100.0% | 320 | 0.0% | 0.00% | +200.0% |
| Q4 2022 | $3 | -99.9% | 320 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $3,000 | 0.0% | 320 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $3,000 | -25.0% | 320 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $4,000 | -63.6% | 320 | 0.0% | 0.00% | -60.0% |
| Q4 2021 | $11,000 | -26.7% | 320 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $15,000 | +7.1% | 320 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $14,000 | -6.7% | 320 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $15,000 | -11.8% | 320 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $17,000 | +88.9% | 320 | +28.0% | 0.01% | +60.0% |
| Q3 2020 | $9,000 | +12.5% | 250 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $8,000 | +14.3% | 250 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $7,000 | – | 250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |